Requires NJT to establish pilot program to supply certain light rail train sets with opioid antidotes; makes appropriation of $100,000.

This bill (S 1808) requires New Jersey Transit (NJT) to implement a two-year pilot program on light rail trains operating in southern New Jersey. It mandates that NJT stock opioid antidotes (like naloxone) on all such trains, including secure storage with silent alerts for train operators, two doses per train, and multilingual informational cards for passengers. The program requires NJT staff to maintain supplies and records but does not require staff to administer the antidote or receive specialized training. The state appropriates $100,000 for implementation, and NJT must report on the pilot's effectiveness to the Governor and Legislature within six months of its conclusion. The pilot targets light rail passengers and staff in southern New Jersey, focusing on rapid response to opioid overdoses during transit.